Zacks Research analysts have increased their earnings estimates for Eastman Chemical Company, projecting an EPS of $1.87 for Q1 2026. The revised forecast reflects growing confidence in the company’s financial trajectory within the basic materials sector.

Merck & Co., Inc. is projected to achieve an earnings per share of $9.62 in fiscal year 2026, according to new estimates released by Cantor Fitzgerald analyst C. Gould. The research note was issued to investors on June 9th.

HC Wainwright has lifted its first-quarter 2025 earnings estimates for Alumis Inc., with analyst M. Kapoor now forecasting a loss of ($1.03) per share. The upward revision signals increased confidence in the company’s financial outlook.